I'm still not really happy to be on this drug, although I have no history of heart problems in my family that I know of, so the risk of heart attack should be small. And the studies are conflicting and flawed. So for now I'll stay on it.
Diabetes drug Avandia should stay on market: U.S. health panel rules
| Unshelved | by Bill Barnes and Gene Ambaum |
|
|
No comments:
Post a Comment